Retrospective Chart Review of Cardiovascular Outcomes Among Patients Receiving Chimeric Antigen Receptors T-cell Therapy
S
Suparna C. Clasen, MD, MSCE
Primary Investigator
Enrolling By Invitation
100 years and younger
All
Phase
N/A
1 Location
Brief description of study
What is the purpose of this study?
The purpose of this study is to determine the incidence and characterize the nature of cardiovascular adverse events occurring following CAR T-cell therapy, including arrhythmia, cardiac ischemia, myocarditis, and heart failure, and the therapeutic modalities used to treat these cardiovascular events.
THIS STUDY IS DATA COLLECTION ONLY AND IS NOT ENROLLING PARTICIPANTS
Detailed description of study
What will happen during the study?
- Data collection that does not include interacting with subjects.
- Researchers on this study will also assess whether cardiovascular outcomes post-CAR T-cell therapy are associated with baseline demographic and clinical characteristics.
- Research data will be gathered from IU and sent to MSKCC
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Cancer
-
Age: - 100 Years
-
Gender: All
Updated on
28 Aug 2024.
Study ID: KIC-CLASEN-MSKCART, 16666
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
